Table 2 Univariate and multivariate analysis of patients in stage IC AGCT
Factors | 5 year DFS rate (%) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
Menopause | 0.065 | ||||
Yes | 100 | 1 | |||
No | 75.4 | 0.183 (0.024–1.391) | |||
Surgery | 0.003 | 0.032 | |||
Staging | 93.8 | 1 | 1 | ||
Unstaged | 70.6 | 4.95 (1.557–15.792) | 3.883 (1.123–13.430) | ||
Stage | 0.971 | ||||
IC1 | 76.9 | 1 | |||
IC2-IC3 | 80.8 | 1.019 (0.368–2.819) | |||
Adjuvant chemotherapy | 0.197 | ||||
No | 76.3 | 1 | |||
Yes | 87.5 | 0.517 (0.186–1.433) | |||
Initial treatment | 0.038 | 0.345 | 0.345 | ||
Our clinical | 91.9 | 1 | 1 | ||
Outer | 72.2 | 2.984 (1.012–8.799) | 1.747 (0.549–5.562) | ||
Lymph node dissection | 0.386 | ||||
Yes | 87.8 | 1 | |||
No | 76.1 | 1.578 (0.557–4.472) | |||